# The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care

> **NCT04541381** · NA · SUSPENDED · sponsor: **University of Chicago** · enrollment: 860 (estimated)

## Conditions studied

- Gastrointestinal Cancer
- Head and Neck Cancer
- Dihydropyrimidine Dehydrogenase Deficiency
- UGT1A1 Gene Mutation
- Breast Cancer

## Interventions

- **OTHER:** Availability of clinical decision support based on pharmacogenomic results.

## Key facts

- **NCT ID:** NCT04541381
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2022-02-07
- **Primary completion:** 2027-10-01
- **Final completion:** 2028-03-31
- **Target enrollment:** 860 (ESTIMATED)
- **Why stopped:** pending study amendment/re-design
- **Last updated:** 2026-05-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04541381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04541381, "The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT04541381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*